Patently-O

Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly

Federal Circuit denies en banc review in Teva v. Lilly over Judge Dyk's dissent, leaving method claims to an antibody genus intact after Amgen. Continue reading this post on Patently-O.

By Patently-O

1 min read
Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly
Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Intellectual Property Law

Related Insights